| Authors: |
Smith-Roe SL; Division of Translational Toxicology, NIEHS, Research Triangle Park, NC., Hobbs CA; Integrated Laboratory Systems, LLC (an Inotiv company), Research Triangle Park, NC., Hull V; Integrated Laboratory Systems, LLC (an Inotiv company), Research Triangle Park, NC., Auman JT; Integrated Laboratory Systems, LLC (an Inotiv company), Research Triangle Park, NC., Recio L; Integrated Laboratory Systems, LLC (an Inotiv company), Research Triangle Park, NC., Streicker MA; Integrated Laboratory Systems, LLC (an Inotiv company), Research Triangle Park, NC., Rivas MV; Integrated Laboratory Systems, LLC (an Inotiv company), Research Triangle Park, NC., Pratt GA; TwinStrand Biosciences, Inc., Seattle, WA., Lo FY; TwinStrand Biosciences, Inc., Seattle, WA., Higgins JE; TwinStrand Biosciences, Inc., Seattle, WA., Schmidt EK; TwinStrand Biosciences, Inc., Seattle, WA., Williams LN; TwinStrand Biosciences, Inc., Seattle, WA., Nachmanson D; TwinStrand Biosciences, Inc., Seattle, WA., Valentine CC 3rd; TwinStrand Biosciences, Inc., Seattle, WA., Salk JJ; TwinStrand Biosciences, Inc., Seattle, WA., Witt KL; Division of Translational Toxicology, NIEHS, Research Triangle Park, NC. |
